NLRP3 and neoplasm: Finally, while chitosan represents a promising NLRP3-targeted immunomodulator, its translation will require careful optimization of dosing regimens, combinatorial strategies, and patient stratification to balance anti-tumor efficacy with inflammatory toxicity-a challenge reflective of the broader inflammasome therapeutics field.